| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000334065 |
| P698 | PubMed publication ID | 22086062 |
| P2093 | author name string | G H Schuring-Blom | |
| K D Lichtenbelt | |||
| N V A M Knoers | |||
| P2860 | cites work | Donnai-Barrow syndrome (DBS/FOAR) in a child with a homozygous LRP2 mutation due to complete chromosome 2 paternal isodisomy | Q24629748 |
| Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies | Q28752220 | ||
| Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size | Q29544005 | ||
| Prospective ranking of the sonographic markers for aneuploidy: data of 2143 prenatal cytogenetic diagnoses referred for abnormalities on ultrasound. | Q30794929 | ||
| Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases | Q30830662 | ||
| Array comparative genomic hybridization and flow cytometry analysis of spontaneous abortions and mors in utero samples. | Q33502884 | ||
| Digital fetal aneuploidy diagnosis by next-generation sequencing | Q44639608 | ||
| Revisiting the risk for aneuploidy in fetuses with isolated pyelectasis | Q45823428 | ||
| Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysis | Q46166434 | ||
| Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment | Q50128700 | ||
| Bi-color detection of two target DNAs by non-radioactive in situ hybridization. | Q50911710 | ||
| Comparison of targeted and whole genome analysis of postnatal specimens using a commercially available array based comparative genomic hybridisation (aCGH) microarray platform. | Q51576131 | ||
| Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. | Q51650782 | ||
| An algorithm for the prenatal detection of chromosome anomalies by QF-PCR and G-banded analysis. | Q51862044 | ||
| High resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings. | Q51934404 | ||
| Pregnancy complicated by triploidy: a comparison of the three karyotypes. | Q53398575 | ||
| Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization. | Q54445819 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Prenatal diagnosis of chromosomal abnormalities using array-based comparative genomic hybridization | Q57537925 | ||
| Application of a target array comparative genomic hybridization to prenatal diagnosis | Q33615322 | ||
| Fetal cells in the maternal circulation: feasibility for prenatal diagnosis | Q33650187 | ||
| Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation | Q33664901 | ||
| Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages | Q33910274 | ||
| Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities | Q34149751 | ||
| Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. | Q34168875 | ||
| Molecular hybridization of radioactive DNA to the DNA of cytological preparations | Q34230191 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? | Q34921561 | ||
| Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. | Q35216798 | ||
| Evolving applications of microarray analysis in prenatal diagnosis | Q35255522 | ||
| Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations | Q35447657 | ||
| Congenital heart disease and aneuploidy | Q35991619 | ||
| How unexpected are unexpected findings in prenatal cytogenetic diagnosis? A literature review | Q36113314 | ||
| Prenatal diagnosis by array-CGH. | Q36265171 | ||
| Comparative genomic hybridization and prenatal diagnosis | Q36443234 | ||
| Molecular cytogenetic and rapid aneuploidy detection methods in prenatal diagnosis | Q36732301 | ||
| What's new in karyotyping? The move towards array comparative genomic hybridisation (CGH). | Q36764556 | ||
| Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation | Q36806004 | ||
| Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases | Q36881942 | ||
| Prenatal detection of unbalanced chromosomal rearrangements by array CGH. | Q36927206 | ||
| The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future | Q36957670 | ||
| Prenatal testing for uniparental disomy: indications and clinical relevance | Q37024304 | ||
| Genomic medicine in prenatal diagnosis | Q37095879 | ||
| Ethical challenges in providing noninvasive prenatal diagnosis | Q37680643 | ||
| Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis | Q37775574 | ||
| Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies | Q37840679 | ||
| Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era? | Q37849711 | ||
| aCGH on chorionic villi mirrors the complexity of fetoplacental mosaicism in prenatal diagnosis | Q39586170 | ||
| Diagnosis of miscarriages by molecular karyotyping: benefits and pitfalls | Q39961900 | ||
| Incidence and significance of chromosome mosaicism involving an autosomal structural abnormality diagnosed prenatally through amniocentesis: a collaborative study | Q41248813 | ||
| Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. | Q41343970 | ||
| Somatic mosaicism in cases with small supernumerary marker chromosomes | Q42040542 | ||
| Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray | Q43531050 | ||
| Fetal ultrasound abnormalities: correlation with fetal karyotype, autopsy findings, and postnatal outcome--five-year prospective study | Q43636384 | ||
| Changes in the utilization of prenatal diagnosis | Q44119649 | ||
| The detection of chromosome anomalies by QF-PCR and residual risks as compared to G-banded analysis | Q44616121 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | karyotype | Q189967 |
| P304 | page(s) | 241-250 | |
| P577 | publication date | 2011-11-12 | |
| P1433 | published in | Cytogenetics and Genome Research | Q1524623 |
| P1476 | title | From karyotyping to array-CGH in prenatal diagnosis | |
| P478 | volume | 135 |
| Q30619280 | 22q11.2 deletions in patients with conotruncal defects: data from 1,610 consecutive cases |
| Q54265517 | A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. |
| Q37734319 | A prenatal missed diagnosed case of submicroscopic chromosomal abnormalities by karyotyping: the clinical utility of array-based CGH in prenatal diagnostics |
| Q37532317 | Best diagnostic approach for the genetic evaluation of fetuses after intrauterine death in first, second or third trimester: QF-PCR, karyotyping and/or genome wide SNP array analysis |
| Q53944182 | Congenital diaphragmatic hernia interval on chromosome 8p23.1 characterized by genetics and protein interaction networks. |
| Q41260566 | Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing? |
| Q35827874 | Do physicians think genomic medicine will be useful for patient care? |
| Q27024633 | Human molecular cytogenetics: From cells to nucleotides |
| Q41938125 | Implementation of high resolution whole genome array CGH in the prenatal clinical setting: advantages, challenges, and review of the literature |
| Q50856798 | Microdeletions/duplications involving TBX1 gene in fetuses with conotruncal heart defects which are negative for 22q11.2 deletion on fluorescence in-situ hybridization. |
| Q42326536 | Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes |
| Q34306076 | Prenatal diagnosis of a de novo interstitial deletion of 11q (11q22.3 → q23.3) associated with abnormal ultrasound findings by array comparative genomic hybridization |
| Q92063371 | Prenatal diagnosis of a maternal 7.22-Mb deletion at chromosome 4q32.2q32.3 by SNP array |
| Q38932388 | Prevalence, diagnosis and outcome of cleft lip with or without cleft palate in The Netherlands |
| Q48217175 | Prevalence, timing of diagnosis and pregnancy outcome of abdominal wall defects after the introduction of a national prenatal screening program |
| Q55692874 | Supernumerary marker chromosomes derived from chromosome 6: cytogenetic, molecular cytogenetic, and array CGH characterization. |
| Q53131950 | The introduction of arrays in prenatal diagnosis: a special challenge. |
| Q38088010 | The role of high-throughput technologies in clinical cancer genomics |
| Q37424832 | Women's experiences receiving abnormal prenatal chromosomal microarray testing results |
Search more.